Cargando…
Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life
BACKGROUND: Low-dose-rate permanent prostate brachytherapy (PPB) is an attractive treatment option for patients with localised prostate cancer with excellent outcomes. As standard CT-based post-implant dosimetry often correlates poorly with late treatment-related toxicity, this exploratory (proof of...
Autores principales: | Osman, Sarah O. S., Horn, Simon, Brady, Darren, McMahon, Stephen J., Yoosuf, Ahamed B. Mohamed, Mitchell, Darren, Crowther, Karen, Lyons, Ciara A., Hounsell, Alan R., Prise, Kevin M., McGarry, Conor K., Jain, Suneil, O’Sullivan, Joe M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348795/ https://www.ncbi.nlm.nih.gov/pubmed/28288658 http://dx.doi.org/10.1186/s13014-017-0792-1 |
Ejemplares similares
-
A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
por: Lyons, Ciara A., et al.
Publicado: (2017) -
DNA Damage Responses following Exposure to Modulated Radiation Fields
por: Trainor, Colman, et al.
Publicado: (2012) -
Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
por: Osman, Sarah O. S., et al.
Publicado: (2019) -
A Kinetic-Based Model of Radiation-Induced Intercellular Signalling
por: McMahon, Stephen J., et al.
Publicado: (2013) -
Class solutions for SABR-VMAT for high-risk prostate cancer with and without elective nodal irradiation
por: Osman, Sarah O. S., et al.
Publicado: (2016)